Launch week offerEnds in00h00m00s

annual Promonthly Pro

Michal Vocka

Head of Department

General University Hospital in Prague

Czech Republic

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Cell Biology

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (6)

Blanca Gil Ibañez

MD, PhD

Hospital Universitario 12 de Octubre

SPAIN

View details

Petr Hosek

Charles University

CZECH REPUBLIC

View details

Madiha Kanwal

Senior Researcher

Charles University

CZECH REPUBLIC

View details

Marketa Janatova

Assistanf Professor and researcher

Přírodovědecká Fakulta, Univerzita Karlova

CZECH REPUBLIC

View details

Matouš Palek

Institute of Molecular Genetics

CZECH REPUBLIC

View details

Zdenek Kleibl

Laboratory of oncogenetics (head)

Charles University, First Faculty of Medicine

CZECH REPUBLIC

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michal Vocka

Research Interests

Make your next move.

Explore related searches

Articles (20)

Case Report: Aplastic anemia associated with parvovirus B19 infection following neoadjuvant pembrolizumab-based chemoimmunotherapy for triple-negative breast cancer

Colorectal cancer detection using noncontrast CT and deep learning: a multicenter and international cohort study

DEL-LIVER: An open-label, randomized phase II study of melphalan/HDS induction followed by standard therapy vs standard therapy alone in patients with liver-dominant refractory metastatic colorectal cancer

Nivolumab in previously treated metastatic renal cell carcinoma: real-world data from the Czech Republic and Slovakia

Oncofertility in gastrointestinal (GI) oncology: A Pan-European study of the patient perspective

Oncofertility in gastrointestinal oncology: a pan-European study of the patient perspective

The Prognostic Role of Baseline and Early Dynamics of Peripheral Blood Cell Ratios in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab

European training requirements for gynecological oncology: the European Society of Gynaecological Oncology Curriculum

Prognostic Value of Hematologic Indices and Composite Models in Anal Squamous Cell Carcinoma Treated with Image-Guided Chemoradiotherapy

Baseline and early changes in eosinophil count and neutrophil-to-eosinophil ratio predict outcomes in metastatic renal cell carcinoma treated with nivolumab

Genetic and Non-Genetic Risk Factors in Prostate Cancer: Towards a Precision Medicine Approach

Impact of concomitant use of proton pump inhibitors or cardiovascular medication on survival outcomes of patients with metastatic renal cell carcinoma treated with nivolumab

Isolated Limb Perfusion Can Avert Amputation Indication in Initially Nonsalvageable Sarcomas of the Extremities

Molecular profiles and genomic therapy in young vs. average-onset gastrointestinal (GI) cancers: A Czech national precision medicine network study, GENESIS

A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer.

A deep intronic recurrent CHEK2 variant c.1009-118_1009-87delinsC affects pre-mRNA splicing and contributes to hereditary breast cancer predisposition

A comprehensive analysis of germline predisposition to early-onset ovarian cancer.

Does Extraesophageal Reflux Support the Development of Lung Adenocarcinoma? Analysis of Pepsin in Bronchoalveolar Lavage in Non-Smoker Patients

Comparative Study on Handheld, Modular, and Laboratory Raman Instruments for the Analysis of Colon Tissues and Colorectal Polyps

Genetic Predisposition to Male Breast Cancer

Collaborators (6)

Blanca Gil Ibañez

Petr Hosek

Madiha Kanwal

Marketa Janatova

Matouš Palek

Zdenek Kleibl

Make your next move.